Bogle Investment Management’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-41,982
| Closed | -$707K | – | 354 |
|
|
2018
Q2 | $707K | Sell |
41,982
-287
| -0.7% | -$4.83K | 0.05% | 229 |
|
|
2018
Q1 | $968K | Sell |
42,269
-249,741
| -86% | -$5.72M | 0.07% | 227 |
|
|
2017
Q4 | $7.55M | Buy |
+292,010
| New | +$7.55M | 0.55% | 77 |
|
|
2016
Q3 | – | Sell |
-11,909
| Closed | -$133K | – | 469 |
|
|
2016
Q2 | $133K | Sell |
11,909
-8,691
| -42% | -$97.1K | 0.01% | 370 |
|
|
2016
Q1 | $281K | Sell |
20,600
-128,235
| -86% | -$1.75M | 0.02% | 355 |
|
|
2015
Q4 | $2.82M | Sell |
148,835
-87,682
| -37% | -$1.66M | 0.2% | 145 |
|
|
2015
Q3 | $4.44M | Buy |
+236,517
| New | +$4.44M | 0.32% | 116 |
|
|
2015
Q1 | – | Sell |
-113,894
| Closed | -$1.52M | – | 436 |
|
|
2014
Q4 | $1.52M | Buy |
+113,894
| New | +$1.52M | 0.1% | 224 |
|